Independent Management and New Corporate Advisers Will
Reinforce Reputation at the Forefront of the Global Cannabis
Industry
ECH Media & Data and ECH Medical Will Pursue Two Very
Distinct Growth Strategies
LONDON, June 25, 2019 /PRNewswire/ -- ECH (European
Cannabis Holdings), the London based group of
companies with a fundamental anchor in the global cannabis
market, intends to demerge its operating companies and roll out two
separate holding companies with a new management team and
stand-alone growth strategy for each.
Jeremy Edelman, Chairman,
commented: "Our investment and incubation model has proved to be
highly successful over the last 18 months. We put this down to a
genuine understanding of cannabis and emerging markets, clarity of
vision, strong strategic execution and an exceptionally talented
team. This industry is now maturing and opening up at pace, so we
are proud to announce this demerger which ensures independence and
integrity across two distinctly different propositions."
The company has engaged a new advisory team of Strand Hanson,
Hill Dickinson and PKF to support and advise on the demerger and
associated future transactions.
ECH MEDIA & DATA
This new company will focus on delivering the industry's only
truly global offering across data, intelligence, consultancy and
networking.
The following brands will form the key pillars of
growth:
- Prohibition Partners, the world's leading provider of
data and intelligence for the cannabis industry
- Cannabis Europa, the highly respected conference series
that is widely attended by governments, regulators and
investors
- European Cannabis Week, the influential business
platform and event that will see thousands of global industry
figures convene in London every
June
The company will be headquartered in London, UK, with the tech & data team in
Dublin, Ireland and the
consultancy & regulatory affairs team in Barcelona, Spain.
Leadership will consist of Jeremy
Edelman (Chairman), Stephen
Murphy (CEO) and Daragh
Anglim (MD, Prohibition Partners). Cannabis Europa and
European Cannabis Week are joint ventures.
ECH MEDICAL
A new medical holding company will take a comprehensive approach
to improving access to medical cannabis for eligible patients
around Europe by providing key
infrastructure and educational services.
It will include the following subsidiaries:
- The Medical Cannabis Clinics, the UK's first chain of
private clinics, which will also be rolled out across other
European countries later this year
- The Academy of Medical Cannabis, the online learning
platform for healthcare professionals, with a growing presence
around the world including UK, Ireland, France, Brazil and New
Zealand
- Astral Health, the gateway to the European cannabis
market, with import licenses in place or being finalised across
multiple jurisdictions
Dean Friday, previously ECH's
CFO, will take the reigns as CEO and will be joined on the
leadership team by Prof. Mike Barnes
(Chairman), Hannah Simon (COO),
Jonathan Nadler (MD, Academy),
Robert Whitehouse (MD, Astral) and
Richard North (MD, Clinics). New
Country Managers are being recruited at present for key European
markets.
Hannah Deacon, the tireless
campaigner for UK access to medical cannabis for her young son
Alfie Dingley and other children,
will be Patient Advocacy Specialist.
The wider medical and scientific team includes Dr David Mc Dowell, Dr Elizabeth Iveson, Dr Dani Gordon, and Dr Leon
Barron as well as a number of highly respected specialist
physicians in the UK and general practitioners across Europe.
Logo: https://mma.prnewswire.com/media/813128/ECH_Logo.jpg